Results 181 to 190 of about 23,536 (264)

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Gurney J, Gandhi-Patel B, Unger N, Mordi U, Chen M, Jarrett J, Sherman EM, Mounzer K, Khalsa AM, Dinges WL, McKellar MS, Lipps A.   +17 more
europepmc   +1 more source

Five-Year Immune Recovery After ART Initiation Among PLWH Aged ≥15 Years with Baseline Immunosuppression - China, 2013-2024. [PDF]

China CDC Wkly
Geng Y, Jia H, Guan Y, Ren R, Zhao D, Gan X, Huang L, Liu N, Peng Z, Zhao Y.   +9 more
europepmc   +1 more source

Cytomegalovirus Viremia Is Associated With Mortality Among Children With HIV Starting Antiretroviral Therapy in Sub-Saharan Africa. [PDF]

Clin Infect Dis
Fisayo T, Evans C, Mutasa K, Alber D, Spyer MJ, Rukobo S, Bwakura-Dangarembizi M, Musiime V, Nathoo KJ, Kekitiinwa A, Kityo C, Gibb DM, Klein N, Walker AS, Prendergast AJ.   +14 more
europepmc   +1 more source

Editorial: Towards control of the HIV epidemic: trends in epidemiology and emerging drug resistance in the integrase inhibitor era. [PDF]

Front Epidemiol
Ripamonti D, Santoro M, Fokam J, Ceccherini Silberstein F, Llibre JM.   +4 more
europepmc   +1 more source

HIV-1 Drug Resistance Mutations in Children: A Systematic Review of Global Genotypic Evidence (2014-2026). [PDF]

Pathogens
Jouf G, Alami AB, Maazaz N, Benchekroun S, Elharti E, Belbacha I, Ihazmad H, Jaoudi RE, Benhida R, Rchiad Z, Oumzil H.   +10 more
europepmc   +1 more source

Changes in weight and glycemia after initiation of integrase strand transfer inhibitors among people with HIV and diabetes. [PDF]

AIDS
Hwang YJ, Lesko CR, Brown TT, Alexander GC, Althoff KN, Falade-Nwulia O, Moore RD, Zalla LC, Tseng E, Koethe JR, Rebeiro PF, Marconi VC, Silverberg MJ, Horberg MA, Davy-Mendez T, Lang R, Kassaye SG, Fojo AT, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA).   +18 more
europepmc   +1 more source

Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and Pretreated People Living With HIV Who are Virologically Suppressed, in Routine Clinical Care in France: Results From the CARAVEL Study. [PDF]

Open Forum Infect Dis
Philibert P, Charpentier C, Naguleswaran N, Philippe C, Ajrouche R, Roustand L, Vouillot C, Hocqueloux L.   +7 more
europepmc   +1 more source

A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval. [PDF]

Antimicrob Agents Chemother
Charpentier C, Montrouge T, Wirden M, Avettand-Fenoel V, Tumiotto C, Bellecave P, Rodallec A, Garnier E, Fofana D, Lambert-Niclot S, Montès B, Chaix M-L, Charre C, Gantner P, Bouvier-Alias M, Alidjinou EK, Coulon P, Mchantaf G, Beby-Defaux A, Alessandri-Gradt E, Moisan A, Le Hingrat Q, Lê M, Delaugerre C, Marcelin A-G, Peytavin G, Calvez V, Descamps D, Lenacapavir Observatory Study Group.   +28 more
europepmc   +1 more source

Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study). [PDF]

Infect Dis Ther
Gagliardini R, Caioli A, Fusto M, Ottou S, Forbici F, Fabeni L, Maggi F, Plazzi MM, De Zottis F, Bellagamba R, Paulicelli J, Mastrorosa I, Grilli E, Pinnetti C, Mazzotta V, Caldera R, Forcina G, Antinori A.   +17 more
europepmc   +1 more source

Transmitted HIV-1 drug resistance and subtype distribution among treatment-naïve individuals at a tertiary referral centre in the Aegean Region of Türkiye: an eight-year cohort study. [PDF]

Infection
Ödemiş İ, Akbulut İ, Öz ED, Harput AC, Özcan BY, Demir T, Atalay S.   +6 more
europepmc   +1 more source